Copyright Reports & Markets. All rights reserved.

Global Ioversol Injection Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Ioversol Injection by Type
    • 1.3.1 Overview: Global Ioversol Injection Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Ioversol Injection Consumption Value Market Share by Type in 2025
    • 1.3.3 50mL
    • 1.3.4 75mL
    • 1.3.5 100mL
    • 1.3.6 125mL
  • 1.4 Global Ioversol Injection Market by Application
    • 1.4.1 Overview: Global Ioversol Injection Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Ioversol Injection Market Size & Forecast
  • 1.6 Global Ioversol Injection Market Size and Forecast by Region
    • 1.6.1 Global Ioversol Injection Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Ioversol Injection Market Size by Region, (2021-2032)
    • 1.6.3 North America Ioversol Injection Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Ioversol Injection Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Ioversol Injection Market Size and Prospect (2021-2032)
    • 1.6.6 South America Ioversol Injection Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Ioversol Injection Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 GUERBET
    • 2.1.1 GUERBET Details
    • 2.1.2 GUERBET Major Business
    • 2.1.3 GUERBET Ioversol Injection Product and Solutions
    • 2.1.4 GUERBET Ioversol Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GUERBET Recent Developments and Future Plans
  • 2.2 Liebel-Flarsheim Company LLC
    • 2.2.1 Liebel-Flarsheim Company LLC Details
    • 2.2.2 Liebel-Flarsheim Company LLC Major Business
    • 2.2.3 Liebel-Flarsheim Company LLC Ioversol Injection Product and Solutions
    • 2.2.4 Liebel-Flarsheim Company LLC Ioversol Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Liebel-Flarsheim Company LLC Recent Developments and Future Plans
  • 2.3 Hengrui Pharmaceuticals
    • 2.3.1 Hengrui Pharmaceuticals Details
    • 2.3.2 Hengrui Pharmaceuticals Major Business
    • 2.3.3 Hengrui Pharmaceuticals Ioversol Injection Product and Solutions
    • 2.3.4 Hengrui Pharmaceuticals Ioversol Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Hengrui Pharmaceuticals Recent Developments and Future Plans
  • 2.4 Neptunus Bio-pharmaceutical
    • 2.4.1 Neptunus Bio-pharmaceutical Details
    • 2.4.2 Neptunus Bio-pharmaceutical Major Business
    • 2.4.3 Neptunus Bio-pharmaceutical Ioversol Injection Product and Solutions
    • 2.4.4 Neptunus Bio-pharmaceutical Ioversol Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Neptunus Bio-pharmaceutical Recent Developments and Future Plans
  • 2.5 Bayer HealthCare Pharmaceuticals
    • 2.5.1 Bayer HealthCare Pharmaceuticals Details
    • 2.5.2 Bayer HealthCare Pharmaceuticals Major Business
    • 2.5.3 Bayer HealthCare Pharmaceuticals Ioversol Injection Product and Solutions
    • 2.5.4 Bayer HealthCare Pharmaceuticals Ioversol Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bayer HealthCare Pharmaceuticals Recent Developments and Future Plans
  • 2.6 Bracco Imaging S.p.A.
    • 2.6.1 Bracco Imaging S.p.A. Details
    • 2.6.2 Bracco Imaging S.p.A. Major Business
    • 2.6.3 Bracco Imaging S.p.A. Ioversol Injection Product and Solutions
    • 2.6.4 Bracco Imaging S.p.A. Ioversol Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bracco Imaging S.p.A. Recent Developments and Future Plans
  • 2.7 Zhejiang Starry Pharmaceutical
    • 2.7.1 Zhejiang Starry Pharmaceutical Details
    • 2.7.2 Zhejiang Starry Pharmaceutical Major Business
    • 2.7.3 Zhejiang Starry Pharmaceutical Ioversol Injection Product and Solutions
    • 2.7.4 Zhejiang Starry Pharmaceutical Ioversol Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Zhejiang Starry Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Ioversol Injection Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Ioversol Injection by Company Revenue
    • 3.2.2 Top 3 Ioversol Injection Players Market Share in 2025
    • 3.2.3 Top 6 Ioversol Injection Players Market Share in 2025
  • 3.3 Ioversol Injection Market: Overall Company Footprint Analysis
    • 3.3.1 Ioversol Injection Market: Region Footprint
    • 3.3.2 Ioversol Injection Market: Company Product Type Footprint
    • 3.3.3 Ioversol Injection Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Ioversol Injection Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Ioversol Injection Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Ioversol Injection Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Ioversol Injection Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Ioversol Injection Consumption Value by Type (2021-2032)
  • 6.2 North America Ioversol Injection Market Size by Application (2021-2032)
  • 6.3 North America Ioversol Injection Market Size by Country
    • 6.3.1 North America Ioversol Injection Consumption Value by Country (2021-2032)
    • 6.3.2 United States Ioversol Injection Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Ioversol Injection Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Ioversol Injection Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Ioversol Injection Consumption Value by Type (2021-2032)
  • 7.2 Europe Ioversol Injection Consumption Value by Application (2021-2032)
  • 7.3 Europe Ioversol Injection Market Size by Country
    • 7.3.1 Europe Ioversol Injection Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Ioversol Injection Market Size and Forecast (2021-2032)
    • 7.3.3 France Ioversol Injection Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Ioversol Injection Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Ioversol Injection Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Ioversol Injection Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Ioversol Injection Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Ioversol Injection Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Ioversol Injection Market Size by Region
    • 8.3.1 Asia-Pacific Ioversol Injection Consumption Value by Region (2021-2032)
    • 8.3.2 China Ioversol Injection Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Ioversol Injection Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Ioversol Injection Market Size and Forecast (2021-2032)
    • 8.3.5 India Ioversol Injection Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Ioversol Injection Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Ioversol Injection Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Ioversol Injection Consumption Value by Type (2021-2032)
  • 9.2 South America Ioversol Injection Consumption Value by Application (2021-2032)
  • 9.3 South America Ioversol Injection Market Size by Country
    • 9.3.1 South America Ioversol Injection Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Ioversol Injection Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Ioversol Injection Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Ioversol Injection Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Ioversol Injection Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Ioversol Injection Market Size by Country
    • 10.3.1 Middle East & Africa Ioversol Injection Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Ioversol Injection Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Ioversol Injection Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Ioversol Injection Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Ioversol Injection Market Drivers
  • 11.2 Ioversol Injection Market Restraints
  • 11.3 Ioversol Injection Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Ioversol Injection Industry Chain
  • 12.2 Ioversol Injection Upstream Analysis
  • 12.3 Ioversol Injection Midstream Analysis
  • 12.4 Ioversol Injection Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ioversol Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Ioversol Injection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ioversol Injection market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Ioversol Injection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Ioversol Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Ioversol Injection market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ioversol Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ioversol Injection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GUERBET, Liebel-Flarsheim Company LLC, Hengrui Pharmaceuticals, Neptunus Bio-pharmaceutical, Bayer HealthCare Pharmaceuticals, Bracco Imaging S.p.A., Zhejiang Starry Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Ioversol Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    50mL
    75mL
    100mL
    125mL
    Market segment by Application
    Hospital
    Clinic
    Others
    Market segment by players, this report covers
    GUERBET
    Liebel-Flarsheim Company LLC
    Hengrui Pharmaceuticals
    Neptunus Bio-pharmaceutical
    Bayer HealthCare Pharmaceuticals
    Bracco Imaging S.p.A.
    Zhejiang Starry Pharmaceutical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Ioversol Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Ioversol Injection, with revenue, gross margin, and global market share of Ioversol Injection from 2021 to 2026.
    Chapter 3, the Ioversol Injection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Ioversol Injection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Ioversol Injection.
    Chapter 13, to describe Ioversol Injection research findings and conclusion.

    Buy now